Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies
Jing Zhao, Jane Meisel, Yi Guo, Rita Nahta, Kung Lin Hsieh, Limin Peng, Zhimin Wei, Ruth O’Regan, Xiaoxian Li
Topics & Concepts
Breast cancerFOXP3Tumor-infiltrating lymphocytesMedicineOncologyTrastuzumabImmunotherapyTumor microenvironmentCD8Internal medicineNeoadjuvant therapyImmune systemImmunohistochemistryCancerCancer researchImmunologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune cells in cancer